ID   GRIA1_RAT               Reviewed;         907 AA.
AC   P19490;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 2.
DT   02-OCT-2024, entry version 224.
DE   RecName: Full=Glutamate receptor 1 {ECO:0000305};
DE            Short=GluR-1;
DE   AltName: Full=AMPA-selective glutamate receptor 1;
DE   AltName: Full=GluR-A {ECO:0000303|PubMed:2166337};
DE   AltName: Full=GluR-K1 {ECO:0000303|PubMed:2480522};
DE   AltName: Full=Glutamate receptor ionotropic, AMPA 1;
DE   Flags: Precursor;
GN   Name=Gria1 {ECO:0000312|RGD:621531};
GN   Synonyms=GluA1 {ECO:0000303|PubMed:21639859},
GN   Glur1 {ECO:0000303|PubMed:2168579};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FLOP), AND FUNCTION.
RC   TISSUE=Forebrain;
RX   PubMed=2480522; DOI=10.1038/342643a0;
RA   Hollmann M., O'Shea-Greenfield A., Rogers S.W., Heinemann S.F.;
RT   "Cloning by functional expression of a member of the glutamate receptor
RT   family.";
RL   Nature 342:643-648(1989).
RN   [2]
RP   SEQUENCE REVISION.
RA   Hartley M.;
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FLOP), FUNCTION, AND ACTIVITY
RP   REGULATION.
RC   TISSUE=Brain;
RX   PubMed=2166337; DOI=10.1126/science.2166337;
RA   Keinaenen K., Wisden W., Sommer B., Werner P., Herb A., Verdoorn T.A.,
RA   Sakmann B., Seeburg P.H.;
RT   "A family of AMPA-selective glutamate receptors.";
RL   Science 249:556-560(1990).
RN   [4]
RP   SEQUENCE REVISION TO 67; 248; 698; 710; 789 AND 893.
RA   Keinaenen K., Wisden W., Sommer B., Werner P., Herb A., Verdoorn T.A.,
RA   Sakmann B., Seeburg P.H.;
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FLOP), FUNCTION, AND SUBUNIT.
RX   PubMed=2168579; DOI=10.1126/science.2168579;
RA   Boulter J., Hollmann M., O'Shea-Greenfield A., Hartley M., Deneris E.S.,
RA   Maron C., Heinemann S.F.;
RT   "Molecular cloning and functional expression of glutamate receptor subunit
RT   genes.";
RL   Science 249:1033-1037(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FLIP), FUNCTION, AND VARIANT THR-710.
RC   TISSUE=Brain;
RX   PubMed=1699275; DOI=10.1126/science.1699275;
RA   Sommer B., Keinaenen K., Verdoorn T.A., Wisden W., Burnashev N., Herb A.,
RA   Koehler M., Takagi T., Sakmann B., Seeburg P.H.;
RT   "Flip and flop: a cell-specific functional switch in glutamate-operated
RT   channels of the CNS.";
RL   Science 249:1580-1585(1990).
RN   [7]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=1709304; DOI=10.1126/science.1709304;
RA   Hollmann M., Hartley M., Heinemann S.;
RT   "Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on
RT   subunit composition.";
RL   Science 252:851-853(1991).
RN   [8]
RP   PHOSPHORYLATION AT SER-645.
RX   PubMed=7877986; DOI=10.1073/pnas.92.5.1376;
RA   Yakel J.L., Vissavajjhala P., Derkach V.A., Brickey D.A., Soderling T.R.;
RT   "Identification of a Ca2+/calmodulin-dependent protein kinase II regulatory
RT   phosphorylation site in non-N-methyl-D-aspartate glutamate receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:1376-1380(1995).
RN   [9]
RP   VARIANT THR-710, AND PHOSPHORYLATION AT SER-710.
RX   PubMed=8848293; DOI=10.1016/0168-0102(95)00977-9;
RA   Nakazawa K., Tadakuma T., Nokihara K., Ito M.;
RT   "Antibody specific for phosphorylated AMPA-type glutamate receptors at
RT   GluR2 Ser-696.";
RL   Neurosci. Res. 24:75-86(1995).
RN   [10]
RP   PHOSPHORYLATION AT SER-849 AND SER-863, AND MUTAGENESIS OF SER-645 AND
RP   SER-849.
RX   PubMed=9405465; DOI=10.1074/jbc.272.51.32528;
RA   Mammen A.L., Kameyama K., Roche K.W., Huganir R.L.;
RT   "Phosphorylation of the alpha-amino-3-hydroxy-5-methylisoxazole4-propionic
RT   acid receptor GluR1 subunit by calcium/calmodulin-dependent kinase II.";
RL   J. Biol. Chem. 272:32528-32533(1997).
RN   [11]
RP   INTERACTION WITH DLG1.
RX   PubMed=9677374; DOI=10.1074/jbc.273.31.19518;
RA   Leonard A.S., Davare M.A., Horne M.C., Garner C.C., Hell J.W.;
RT   "SAP97 is associated with the alpha-amino-3-hydroxy-5-methylisoxazole-4-
RT   propionic acid receptor GluR1 subunit.";
RL   J. Biol. Chem. 273:19518-19524(1998).
RN   [12]
RP   INTERACTION WITH DLG1, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF THR-905 AND LEU-907.
RX   PubMed=12070168; DOI=10.1074/jbc.m204354200;
RA   Cai C., Coleman S.K., Niemi K., Keinaenen K.;
RT   "Selective binding of synapse-associated protein 97 to GluR-A alpha-amino-
RT   5-hydroxy-3-methyl-4-isoxazole propionate receptor subunit is determined by
RT   a novel sequence motif.";
RL   J. Biol. Chem. 277:31484-31490(2002).
RN   [13]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=11773314; DOI=10.1113/jphysiol.2001.012897;
RA   Jatzke C., Watanabe J., Wollmuth L.P.;
RT   "Voltage and concentration dependence of Ca(2+) permeability in recombinant
RT   glutamate receptor subtypes.";
RL   J. Physiol. (Lond.) 538:25-39(2002).
RN   [14]
RP   INTERACTION WITH PDLIM4, AND SUBCELLULAR LOCATION.
RX   PubMed=15456832; DOI=10.1523/jneurosci.2100-04.2004;
RA   Schulz T.W., Nakagawa T., Licznerski P., Pawlak V., Kolleker A., Rozov A.,
RA   Kim J., Dittgen T., Koehr G., Sheng M., Seeburg P.H., Osten P.;
RT   "Actin/alpha-actinin-dependent transport of AMPA receptors in dendritic
RT   spines: role of the PDZ-LIM protein RIL.";
RL   J. Neurosci. 24:8584-8594(2004).
RN   [15]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND INTERACTION WITH CACNG2.
RX   PubMed=16793768; DOI=10.1074/jbc.m600679200;
RA   Bedoukian M.A., Weeks A.M., Partin K.M.;
RT   "Different domains of the AMPA receptor direct stargazin-mediated
RT   trafficking and stargazin-mediated modulation of kinetics.";
RL   J. Biol. Chem. 281:23908-23921(2006).
RN   [16]
RP   INTERACTION WITH LRFN1.
RX   PubMed=16630835; DOI=10.1016/j.neuron.2006.04.005;
RA   Ko J., Kim S., Chung H.S., Kim K., Han K., Kim H., Jun H., Kaang B.-K.,
RA   Kim E.;
RT   "SALM synaptic cell adhesion-like molecules regulate the differentiation of
RT   excitatory synapses.";
RL   Neuron 50:233-245(2006).
RN   [17]
RP   INTERACTION WITH PRKG2, PHOSPHORYLATION AT SER-863, AND MUTAGENESIS OF
RP   ARG-855 AND SER-863.
RX   PubMed=18031684; DOI=10.1016/j.neuron.2007.09.016;
RA   Serulle Y., Zhang S., Ninan I., Puzzo D., McCarthy M., Khatri L.,
RA   Arancio O., Ziff E.B.;
RT   "A GluR1-cGKII interaction regulates AMPA receptor trafficking.";
RL   Neuron 56:670-688(2007).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH CACNG5.
RX   PubMed=18817736; DOI=10.1016/j.neuron.2008.07.034;
RA   Kato A.S., Siuda E.R., Nisenbaum E.S., Bredt D.S.;
RT   "AMPA receptor subunit-specific regulation by a distinct family of type II
RT   TARPs.";
RL   Neuron 59:986-996(2008).
RN   [19]
RP   INTERACTION WITH CACNG5.
RX   PubMed=19234459; DOI=10.1038/nn.2266;
RA   Soto D., Coombs I.D., Renzi M., Zonouzi M., Farrant M., Cull-Candy S.G.;
RT   "Selective regulation of long-form calcium-permeable AMPA receptors by an
RT   atypical TARP, gamma-5.";
RL   Nat. Neurosci. 12:277-285(2009).
RN   [20]
RP   ERRATUM OF PUBMED:19234459.
RX   DOI=10.1038/nn0609-808c;
RA   Soto D., Coombs I.D., Renzi M., Zonouzi M., Farrant M., Cull-Candy S.G.;
RL   Nat. Neurosci. 12:808-808(2009).
RN   [21]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=19265014; DOI=10.1126/science.1167852;
RA   Schwenk J., Harmel N., Zolles G., Bildl W., Kulik A., Heimrich B.,
RA   Chisaka O., Jonas P., Schulte U., Fakler B., Kloecker N.;
RT   "Functional proteomics identify cornichon proteins as auxiliary subunits of
RT   AMPA receptors.";
RL   Science 323:1313-1319(2009).
RN   [22]
RP   INTERACTION WITH CNIH2 AND CACNG2.
RX   PubMed=20805473; DOI=10.1073/pnas.1011706107;
RA   Shi Y., Suh Y.H., Milstein A.D., Isozaki K., Schmid S.M., Roche K.W.,
RA   Nicoll R.A.;
RT   "Functional comparison of the effects of TARPs and cornichons on AMPA
RT   receptor trafficking and gating.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:16315-16319(2010).
RN   [23] {ECO:0007744|PDB:2AWW, ECO:0007744|PDB:2G2L}
RP   X-RAY CRYSTALLOGRAPHY (2.21 ANGSTROMS) OF 890-907 IN COMPLEX WITH DLG1, AND
RP   INTERACTION WITH DLG1.
RX   PubMed=17069616; DOI=10.1111/j.1742-4658.2006.05521.x;
RA   von Ossowski I., Oksanen E., von Ossowski L., Cai C., Sundberg M.,
RA   Goldman A., Keinanen K.;
RT   "Crystal structure of the second PDZ domain of SAP97 in complex with a
RT   GluR-A C-terminal peptide.";
RL   FEBS J. 273:5219-5229(2006).
RN   [24] {ECO:0007744|PDB:3SAJ}
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 22-392, SUBUNIT, GLYCOSYLATION AT
RP   ASN-63; ASN-249; ASN-257 AND ASN-363, AND DISULFIDE BOND.
RX   PubMed=21639859; DOI=10.1042/bj20110801;
RA   Yao G., Zong Y., Gu S., Zhou J., Xu H., Mathews I.I., Jin R.;
RT   "Crystal structure of the glutamate receptor GluA1 N-terminal domain.";
RL   Biochem. J. 438:255-263(2011).
CC   -!- FUNCTION: Ionotropic glutamate receptor that functions as a ligand-
CC       gated cation channel, gated by L-glutamate and glutamatergic agonists
CC       such as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
CC       (AMPA), quisqualic acid, and kainic acid (PubMed:2166337,
CC       PubMed:2168579). L-glutamate acts as an excitatory neurotransmitter at
CC       many synapses in the central nervous system. Binding of the excitatory
CC       neurotransmitter L-glutamate induces a conformation change, leading to
CC       the opening of the cation channel, and thereby converts the chemical
CC       signal to an electrical impulse upon entry of monovalent and divalent
CC       cations such as sodium and calcium (PubMed:11773314, PubMed:18817736).
CC       The receptor then desensitizes rapidly and enters in a transient
CC       inactive state, characterized by the presence of bound agonist
CC       (PubMed:16793768, PubMed:19265014). In the presence of CACNG2 or CACNG4
CC       or CACNG7 or CACNG8, shows resensitization which is characterized by a
CC       delayed accumulation of current flux upon continued application of L-
CC       glutamate (PubMed:16793768, PubMed:19265014). Resensitization is
CC       blocked by CNIH2 through interaction with CACNG8 in the CACNG8-
CC       containing AMPA receptors complex (By similarity). Calcium (Ca(2+))
CC       permeability depends on subunits composition and, heteromeric channels
CC       containing edited GRIA2 subunit are calcium-impermeable
CC       (PubMed:1709304). Also permeable to other divalents cations such as
CC       strontium(2+) and magnesium(2+) and monovalent cations such as
CC       potassium(1+) and lithium(1+) (PubMed:11773314).
CC       {ECO:0000250|UniProtKB:P42261, ECO:0000269|PubMed:11773314,
CC       ECO:0000269|PubMed:16793768, ECO:0000269|PubMed:1709304,
CC       ECO:0000269|PubMed:18817736, ECO:0000269|PubMed:19265014,
CC       ECO:0000269|PubMed:2166337, ECO:0000269|PubMed:2168579}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Ca(2+)(in) = Ca(2+)(out); Xref=Rhea:RHEA:29671,
CC         ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:11773314,
CC         ECO:0000269|PubMed:1709304};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(in) = Na(+)(out); Xref=Rhea:RHEA:34963,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:11773314,
CC         ECO:0000269|PubMed:1709304};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Mg(2+)(in) = Mg(2+)(out); Xref=Rhea:RHEA:29827,
CC         ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:11773314,
CC         ECO:0000305|PubMed:1709304};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Li(+)(in) = Li(+)(out); Xref=Rhea:RHEA:78551,
CC         ChEBI:CHEBI:49713; Evidence={ECO:0000269|PubMed:11773314,
CC         ECO:0000305|PubMed:1709304};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:11773314, ECO:0000269|PubMed:1709304};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Sr(2+)(in) = Sr(2+)(out); Xref=Rhea:RHEA:78679,
CC         ChEBI:CHEBI:35104; Evidence={ECO:0000269|PubMed:11773314,
CC         ECO:0000305|PubMed:1709304};
CC   -!- ACTIVITY REGULATION: Glutamate-gated receptor activity inhibited by
CC       DNQX (6,7-dinitroquinoxaline-2,3-dione). {ECO:0000269|PubMed:2166337}.
CC   -!- SUBUNIT: Homotetramer or heterotetramer of pore-forming glutamate
CC       receptor subunits; heteromeric assembly can be the result of both
CC       receptor subtype and flip-flop forms and according the composition, one
CC       partner can be dominant with respect to the fast desensitizing current
CC       component, whereas the other can determine the steady-state component
CC       (PubMed:1699275, PubMed:21639859, PubMed:2168579). Tetramers may be
CC       formed by the dimerization of dimers (By similarity). Found in a
CC       complex with GRIA2, GRIA3, GRIA4, CNIH2, CNIH3, CACNG2, CACNG3, CACNG4,
CC       CACNG5, CACNG7 and CACNG8 (PubMed:19265014). Interacts with HIP1 and
CC       RASGRF2. Interacts with SYNDIG1 and GRIA2 (By similarity). Interacts
CC       with DLG1 (via C-terminus) (PubMed:12070168, PubMed:17069616,
CC       PubMed:9677374). Interacts with LRFN1 (PubMed:16630835). Interacts with
CC       PRKG2 (PubMed:18031684). Interacts with CNIH2 and CACNG2
CC       (PubMed:20805473). Interacts with CACNG5; this interaction modulates
CC       the gating (PubMed:18817736, PubMed:19234459). Interacts (via C-
CC       terminus) with PDLIM4 (via LIM domain); this interaction as well as the
CC       interaction of PDLIM4 with alpha-actinin is required for their
CC       colocalization in early endosomes (PubMed:15456832). Interacts with
CC       SNX27 (via PDZ domain); the interaction is required for recycling to
CC       the plasma membrane when endocytosed and prevent degradation in
CC       lysosomes. Interacts (via PDZ-binding motif) with SHANK3 (via PDZ
CC       domain) (By similarity). Interacts with CACNG3; associates GRIA1 with
CC       the adapter protein complex 4 (AP-4) to target GRIA1 to the
CC       somatodendritic compartment of neurons (By similarity). Interacts with
CC       CACNG2; this interaction mediates traffick to the plasma membrane and
CC       modulation of desensitization (PubMed:16793768). Interaction with CNIH2
CC       and CNIH3; this interaction promotes expression at the plasma membrane
CC       and extensively modulates their gating properties by slowing
CC       deactivation and desensitization kinetics (PubMed:19265014). Found in a
CC       complex with GRIA2, GRIA3, GRIA4, DLG4, CACNG8 and CNIH2 (By
CC       similarity). {ECO:0000250|UniProtKB:P23818,
CC       ECO:0000250|UniProtKB:P42261, ECO:0000269|PubMed:12070168,
CC       ECO:0000269|PubMed:15456832, ECO:0000269|PubMed:16630835,
CC       ECO:0000269|PubMed:16793768, ECO:0000269|PubMed:1699275,
CC       ECO:0000269|PubMed:17069616, ECO:0000269|PubMed:18031684,
CC       ECO:0000269|PubMed:18817736, ECO:0000269|PubMed:19234459,
CC       ECO:0000269|PubMed:19265014, ECO:0000269|PubMed:20805473,
CC       ECO:0000269|PubMed:21639859, ECO:0000269|PubMed:2168579,
CC       ECO:0000269|PubMed:9677374}.
CC   -!- INTERACTION:
CC       P19490; P10608: Adrb2; NbExp=3; IntAct=EBI-371642, EBI-7090342;
CC       P19490; Q5FVC2: Arhgef2; NbExp=4; IntAct=EBI-371642, EBI-15756732;
CC       P19490; Q71RJ2: Cacng2; NbExp=7; IntAct=EBI-371642, EBI-8538384;
CC       P19490; P11275: Camk2a; NbExp=3; IntAct=EBI-371642, EBI-2640645;
CC       P19490; Q5BJU5: Cnih2; NbExp=3; IntAct=EBI-371642, EBI-15874082;
CC       P19490; P31016: Dlg4; NbExp=5; IntAct=EBI-371642, EBI-375655;
CC       P19490; P19490: Gria1; NbExp=2; IntAct=EBI-371642, EBI-371642;
CC       P19490; P19491: Gria2; NbExp=3; IntAct=EBI-371642, EBI-77718;
CC       P19490; B2GV74: Klc2; NbExp=2; IntAct=EBI-371642, EBI-978371;
CC       P19490; P70569: Myo5b; NbExp=2; IntAct=EBI-371642, EBI-975940;
CC       P19490-2; P19491-2: Gria2; NbExp=2; IntAct=EBI-26900830, EBI-15817825;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P23818};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P23818}. Endoplasmic
CC       reticulum membrane {ECO:0000269|PubMed:15456832}; Multi-pass membrane
CC       protein {ECO:0000305}. Postsynaptic cell membrane
CC       {ECO:0000250|UniProtKB:P23818}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P23818}. Postsynaptic density membrane
CC       {ECO:0000250|UniProtKB:P23818}; Multi-pass membrane protein
CC       {ECO:0000305}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:P23818}. Cell projection, dendritic spine
CC       {ECO:0000250|UniProtKB:P23818}. Early endosome membrane
CC       {ECO:0000269|PubMed:15456832}; Multi-pass membrane protein
CC       {ECO:0000305}. Recycling endosome membrane
CC       {ECO:0000269|PubMed:15456832}; Multi-pass membrane protein
CC       {ECO:0000305}. Presynapse {ECO:0000250|UniProtKB:P23818}. Synapse
CC       {ECO:0000250|UniProtKB:P23818}. Note=Interaction with CACNG2, CNIH2 and
CC       CNIH3 promotes cell surface expression (PubMed:19265014). Colocalizes
CC       with PDLIM4 in early endosomes (PubMed:15456832). Displays a
CC       somatodendritic localization and is excluded from axons in neurons (By
CC       similarity). Localized to cone photoreceptor pedicles (By similarity).
CC       {ECO:0000250|UniProtKB:P23818, ECO:0000269|PubMed:15456832,
CC       ECO:0000269|PubMed:19265014}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Flop;
CC         IsoId=P19490-1; Sequence=Displayed;
CC       Name=Flip;
CC         IsoId=P19490-2; Sequence=VSP_000097, VSP_000098, VSP_000099,
CC                                  VSP_000100, VSP_000101;
CC   -!- TISSUE SPECIFICITY: Detected in cerebellum (at protein level).
CC       {ECO:0000269|PubMed:12070168}.
CC   -!- DOMAIN: The M4 transmembrane segment mediates tetramerization and is
CC       required for cell surface expression. {ECO:0000250|UniProtKB:P42261}.
CC   -!- PTM: Phosphorylated at Ser-645 (PubMed:7877986). Phosphorylated at Ser-
CC       710 by PKC (PubMed:8848293). Phosphorylated at Ser-849 by PKC, PKA and
CC       CAMK2 (PubMed:9405465). Phosphorylated at Ser-863 by PKC, PKA and PRKG2
CC       (PubMed:18031684, PubMed:9405465). Phosphorylation of Ser-863 is
CC       reduced by induction of long-term depression and increased by induction
CC       of long-term potentiation (By similarity).
CC       {ECO:0000250|UniProtKB:P23818, ECO:0000269|PubMed:18031684,
CC       ECO:0000269|PubMed:7877986, ECO:0000269|PubMed:8848293,
CC       ECO:0000269|PubMed:9405465}.
CC   -!- PTM: Palmitoylated. Depalmitoylated by CPT1C and upon L-glutamate
CC       stimulation. ZDHHC3/GODZ specifically palmitoylates Cys-603, which
CC       leads to Golgi retention and decreased cell surface expression (By
CC       similarity). In contrast, Cys-829 palmitoylation does not affect cell
CC       surface expression but regulates stimulation-dependent endocytosis (By
CC       similarity). {ECO:0000250|UniProtKB:P23818,
CC       ECO:0000250|UniProtKB:P42261}.
CC   -!- POLYMORPHISM: Both variants Ser-710 and Thr-710 are phosphorylated at
CC       this position.
CC   -!- MISCELLANEOUS: The postsynaptic actions of L-glutamate are mediated by
CC       a variety of receptors that are named according to their selective
CC       agonists (Probable). This receptor binds AMPA (quisqualate) > L-
CC       glutamate > kainate (Probable). {ECO:0000305|PubMed:2166337}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC 1.A.10.1)
CC       family. GRIA1 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X17184; CAA35050.1; -; mRNA.
DR   EMBL; M36418; AAA41243.2; -; mRNA.
DR   EMBL; M38060; AAA63479.1; -; mRNA.
DR   PIR; A40170; A40170.
DR   PIR; S07059; ACRTK1.
DR   RefSeq; NP_113796.1; NM_031608.1. [P19490-1]
DR   PDB; 2AWW; X-ray; 2.21 A; C=890-907.
DR   PDB; 2G2L; X-ray; 2.35 A; C/D=890-907.
DR   PDB; 3SAJ; X-ray; 2.50 A; A/B/C/D=22-392.
DR   PDB; 6NJL; EM; 6.70 A; A/C=1-907.
DR   PDB; 6NJN; EM; 6.50 A; A=1-907.
DR   PDB; 6QKC; EM; 4.10 A; A/C=1-907.
DR   PDB; 6QKZ; EM; 6.30 A; A/C=20-907.
DR   PDB; 7OCA; EM; 3.40 A; A/C=1-907.
DR   PDB; 7OCC; EM; 3.40 A; A/C=1-907.
DR   PDB; 7OCD; EM; 3.50 A; A/C=1-907.
DR   PDB; 7OCE; EM; 3.10 A; A/C=1-907.
DR   PDB; 7OCF; EM; 3.60 A; A/C=1-907.
DR   PDB; 7QHB; EM; 3.50 A; A/C=1-907.
DR   PDB; 7QHH; EM; 3.60 A; A/C=1-907.
DR   PDB; 8AYL; EM; 3.20 A; A/C=1-907.
DR   PDB; 8AYM; EM; 3.30 A; A/C=1-907.
DR   PDB; 8AYN; EM; 2.80 A; A/C=1-907.
DR   PDB; 8AYO; EM; 3.30 A; A/C=1-907.
DR   PDB; 8C1P; EM; 2.90 A; A/B/C/D=1-907.
DR   PDB; 8C1Q; EM; 2.82 A; A/B/C/D=1-907.
DR   PDB; 8C2H; EM; 2.64 A; A/B/C/D=1-907.
DR   PDB; 8C2I; EM; 2.70 A; A/B/C/D=1-907.
DR   PDB; 8P3T; EM; 3.39 A; A/B/C/D=1-907.
DR   PDB; 8P3U; EM; 3.77 A; A/B/C/D=1-907.
DR   PDB; 8P3V; EM; 3.53 A; A/B/C/D=1-907.
DR   PDB; 8P3W; EM; 3.53 A; A/B/C/D=1-907.
DR   PDBsum; 2AWW; -.
DR   PDBsum; 2G2L; -.
DR   PDBsum; 3SAJ; -.
DR   PDBsum; 6NJL; -.
DR   PDBsum; 6NJN; -.
DR   PDBsum; 6QKC; -.
DR   PDBsum; 6QKZ; -.
DR   PDBsum; 7OCA; -.
DR   PDBsum; 7OCC; -.
DR   PDBsum; 7OCD; -.
DR   PDBsum; 7OCE; -.
DR   PDBsum; 7OCF; -.
DR   PDBsum; 7QHB; -.
DR   PDBsum; 7QHH; -.
DR   PDBsum; 8AYL; -.
DR   PDBsum; 8AYM; -.
DR   PDBsum; 8AYN; -.
DR   PDBsum; 8AYO; -.
DR   PDBsum; 8C1P; -.
DR   PDBsum; 8C1Q; -.
DR   PDBsum; 8C2H; -.
DR   PDBsum; 8C2I; -.
DR   PDBsum; 8P3T; -.
DR   PDBsum; 8P3U; -.
DR   PDBsum; 8P3V; -.
DR   PDBsum; 8P3W; -.
DR   AlphaFoldDB; P19490; -.
DR   EMDB; EMD-12802; -.
DR   EMDB; EMD-12803; -.
DR   EMDB; EMD-12805; -.
DR   EMDB; EMD-16379; -.
DR   EMDB; EMD-16380; -.
DR   EMDB; EMD-16390; -.
DR   EMDB; EMD-16391; -.
DR   EMDB; EMD-17394; -.
DR   EMDB; EMD-17395; -.
DR   EMDB; EMD-17396; -.
DR   EMDB; EMD-17397; -.
DR   EMDB; EMD-4572; -.
DR   EMDB; EMD-4575; -.
DR   EMDB; EMD-9387; -.
DR   EMDB; EMD-9389; -.
DR   SMR; P19490; -.
DR   BioGRID; 248399; 20.
DR   ComplexPortal; CPX-8766; GluA1-GluA2 AMPA receptor complex.
DR   CORUM; P19490; -.
DR   DIP; DIP-30929N; -.
DR   ELM; P19490; -.
DR   IntAct; P19490; 27.
DR   MINT; P19490; -.
DR   STRING; 10116.ENSRNOP00000074119; -.
DR   BindingDB; P19490; -.
DR   ChEMBL; CHEMBL3753; -.
DR   DrugCentral; P19490; -.
DR   TCDB; 1.A.10.1.1; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   GlyCosmos; P19490; 6 sites, No reported glycans.
DR   GlyGen; P19490; 6 sites.
DR   iPTMnet; P19490; -.
DR   PhosphoSitePlus; P19490; -.
DR   SwissPalm; P19490; -.
DR   PaxDb; 10116-ENSRNOP00000064722; -.
DR   ABCD; P19490; 2 sequenced antibodies.
DR   Ensembl; ENSRNOT00000071615.4; ENSRNOP00000064722.3; ENSRNOG00000045816.4. [P19490-1]
DR   Ensembl; ENSRNOT00000081136.2; ENSRNOP00000074119.2; ENSRNOG00000045816.4. [P19490-2]
DR   Ensembl; ENSRNOT00055051536; ENSRNOP00055042480; ENSRNOG00055029717. [P19490-1]
DR   Ensembl; ENSRNOT00060039317; ENSRNOP00060032516; ENSRNOG00060022487. [P19490-1]
DR   Ensembl; ENSRNOT00065010094; ENSRNOP00065007367; ENSRNOG00065006524. [P19490-1]
DR   GeneID; 50592; -.
DR   KEGG; rno:50592; -.
DR   UCSC; RGD:621531; rat. [P19490-1]
DR   AGR; RGD:621531; -.
DR   CTD; 2890; -.
DR   RGD; 621531; Gria1.
DR   eggNOG; KOG1054; Eukaryota.
DR   GeneTree; ENSGT00940000157342; -.
DR   InParanoid; P19490; -.
DR   OMA; DSDIQHS; -.
DR   OrthoDB; 511851at2759; -.
DR   PhylomeDB; P19490; -.
DR   Reactome; R-RNO-204005; COPII-mediated vesicle transport.
DR   Reactome; R-RNO-399710; Activation of AMPA receptors.
DR   Reactome; R-RNO-399719; Trafficking of AMPA receptors.
DR   Reactome; R-RNO-416993; Trafficking of GluR2-containing AMPA receptors.
DR   Reactome; R-RNO-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-RNO-5694530; Cargo concentration in the ER.
DR   Reactome; R-RNO-8849932; Synaptic adhesion-like molecules.
DR   EvolutionaryTrace; P19490; -.
DR   PRO; PR:P19490; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0032279; C:asymmetric synapse; IDA:RGD.
DR   GO; GO:0044308; C:axonal spine; ISO:RGD.
DR   GO; GO:0044297; C:cell body; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:ARUK-UCL.
DR   GO; GO:0032590; C:dendrite membrane; IDA:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; IDA:ARUK-UCL.
DR   GO; GO:0032591; C:dendritic spine membrane; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; IDA:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0060076; C:excitatory synapse; IDA:BHF-UCL.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0008328; C:ionotropic glutamate receptor complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0044309; C:neuron spine; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:RGD.
DR   GO; GO:0099544; C:perisynaptic space; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; IDA:RGD.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0099092; C:postsynaptic density, intracellular component; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; ISS:UniProtKB.
DR   GO; GO:0048787; C:presynaptic active zone membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:1990635; C:proximal dendrite; IDA:RGD.
DR   GO; GO:0055037; C:recycling endosome; ISO:RGD.
DR   GO; GO:0055038; C:recycling endosome membrane; IDA:UniProtKB.
DR   GO; GO:0036477; C:somatodendritic compartment; ISO:RGD.
DR   GO; GO:0045202; C:synapse; IDA:SynGO-UCL.
DR   GO; GO:0097060; C:synaptic membrane; IDA:ARUK-UCL.
DR   GO; GO:0008021; C:synaptic vesicle; ISO:RGD.
DR   GO; GO:0030672; C:synaptic vesicle membrane; ISO:RGD.
DR   GO; GO:0008179; F:adenylate cyclase binding; IDA:RGD.
DR   GO; GO:0004971; F:AMPA glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:0001540; F:amyloid-beta binding; IPI:ARUK-UCL.
DR   GO; GO:0031698; F:beta-2 adrenergic receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; IPI:RGD.
DR   GO; GO:0031681; F:G-protein beta-subunit binding; IDA:RGD.
DR   GO; GO:0035254; F:glutamate receptor binding; IPI:UniProtKB.
DR   GO; GO:0022849; F:glutamate-gated calcium ion channel activity; IDA:UniProtKB.
DR   GO; GO:0004970; F:glutamate-gated receptor activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0019865; F:immunoglobulin binding; IPI:UniProtKB.
DR   GO; GO:0099507; F:ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; ISO:RGD.
DR   GO; GO:0031489; F:myosin V binding; IPI:RGD.
DR   GO; GO:0099583; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:RGD.
DR   GO; GO:0051428; F:peptide hormone receptor binding; IPI:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0051018; F:protein kinase A binding; IDA:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:SynGO-UCL.
DR   GO; GO:0031267; F:small GTPase binding; IPI:RGD.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0048266; P:behavioral response to pain; IEP:RGD.
DR   GO; GO:0071418; P:cellular response to amine stimulus; IEP:RGD.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEP:RGD.
DR   GO; GO:0071242; P:cellular response to ammonium ion; ISO:RGD.
DR   GO; GO:1990416; P:cellular response to brain-derived neurotrophic factor stimulus; IDA:RGD.
DR   GO; GO:0071359; P:cellular response to dsRNA; IEP:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:1905232; P:cellular response to L-glutamate; IEP:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0071375; P:cellular response to peptide hormone stimulus; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:1990708; P:conditioned place preference; IMP:RGD.
DR   GO; GO:0007616; P:long-term memory; IMP:RGD.
DR   GO; GO:0060292; P:long-term synaptic depression; ISO:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IEP:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IDA:UniProtKB.
DR   GO; GO:0019228; P:neuronal action potential; IMP:UniProtKB.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IMP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0090326; P:positive regulation of locomotion involved in locomotory behavior; IMP:RGD.
DR   GO; GO:0045838; P:positive regulation of membrane potential; IMP:RGD.
DR   GO; GO:0050806; P:positive regulation of synaptic transmission; IMP:UniProtKB.
DR   GO; GO:0031623; P:receptor internalization; IDA:UniProtKB.
DR   GO; GO:0034765; P:regulation of monoatomic ion transmembrane transport; IMP:RGD.
DR   GO; GO:0060078; P:regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0001919; P:regulation of receptor recycling; IMP:UniProtKB.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IMP:UniProtKB.
DR   GO; GO:0046685; P:response to arsenic-containing substance; IEP:RGD.
DR   GO; GO:0042220; P:response to cocaine; IEP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0060992; P:response to fungicide; IEP:RGD.
DR   GO; GO:0010226; P:response to lithium ion; IEP:UniProtKB.
DR   GO; GO:0043278; P:response to morphine; IMP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IDA:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:1990911; P:response to psychosocial stress; IEP:RGD.
DR   GO; GO:0009744; P:response to sucrose; IDA:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IMP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0021510; P:spinal cord development; IEP:RGD.
DR   GO; GO:0007416; P:synapse assembly; ISO:RGD.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IBA:GO_Central.
DR   CDD; cd06390; PBP1_iGluR_AMPA_GluR1; 1.
DR   CDD; cd13729; PBP2_iGluR_AMPA_GluR1; 1.
DR   Gene3D; 1.10.287.70; -; 2.
DR   Gene3D; 3.40.50.2300; -; 2.
DR   Gene3D; 3.40.190.10; Periplasmic binding protein-like II; 2.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_Glu_rcpt_met.
DR   InterPro; IPR015683; Ionotropic_Glu_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt_C.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   PANTHER; PTHR18966:SF157; GLUTAMATE RECEPTOR 1; 1.
DR   PANTHER; PTHR18966; IONOTROPIC GLUTAMATE RECEPTOR; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; Periplasmic binding protein-like I; 1.
DR   SUPFAM; SSF53850; Periplasmic binding protein-like II; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cell projection;
KW   Disulfide bond; Endoplasmic reticulum; Endosome; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..907
FT                   /note="Glutamate receptor 1"
FT                   /id="PRO_0000011531"
FT   TOPO_DOM        19..536
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        537..557
FT                   /note="Helical"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        558..584
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   INTRAMEM        585..600
FT                   /note="Helical; Pore-forming"
FT                   /evidence="ECO:0000250"
FT   INTRAMEM        601..603
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        604..609
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        610..630
FT                   /note="Helical"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        631..805
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        806..826
FT                   /note="Helical; Name=M4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        827..907
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   REGION          857..881
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           904..907
FT                   /note="PDZ-binding"
FT   BINDING         492
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:P42262"
FT   BINDING         494
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:P42262"
FT   BINDING         499
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:P42262"
FT   BINDING         668
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:P42262"
FT   BINDING         669
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:P42262"
FT   BINDING         719
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:P42262"
FT   MOD_RES         645
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:7877986"
FT   MOD_RES         710
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:8848293"
FT   MOD_RES         849
FT                   /note="Phosphoserine; by PKC, PKA and CAMK2"
FT                   /evidence="ECO:0000269|PubMed:7877986,
FT                   ECO:0000269|PubMed:9405465"
FT   MOD_RES         863
FT                   /note="Phosphoserine; by PKC, PKA and PKG/PRKG2"
FT                   /evidence="ECO:0000269|PubMed:18031684,
FT                   ECO:0000269|PubMed:9405465"
FT   LIPID           603
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           829
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        63
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21639859,
FT                   ECO:0007744|PDB:3SAJ"
FT   CARBOHYD        249
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21639859,
FT                   ECO:0007744|PDB:3SAJ"
FT   CARBOHYD        257
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21639859,
FT                   ECO:0007744|PDB:3SAJ"
FT   CARBOHYD        363
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21639859,
FT                   ECO:0007744|PDB:3SAJ"
FT   CARBOHYD        401
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        406
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        75..323
FT                   /evidence="ECO:0000269|PubMed:21639859,
FT                   ECO:0007744|PDB:3SAJ"
FT   DISULFID        732..787
FT                   /evidence="ECO:0000250|UniProtKB:P23818"
FT   VAR_SEQ         758
FT                   /note="N -> G (in isoform Flip)"
FT                   /evidence="ECO:0000303|PubMed:1699275"
FT                   /id="VSP_000097"
FT   VAR_SEQ         768
FT                   /note="N -> S (in isoform Flip)"
FT                   /evidence="ECO:0000303|PubMed:1699275"
FT                   /id="VSP_000098"
FT   VAR_SEQ         772
FT                   /note="L -> V (in isoform Flip)"
FT                   /evidence="ECO:0000303|PubMed:1699275"
FT                   /id="VSP_000099"
FT   VAR_SEQ         778
FT                   /note="N -> S (in isoform Flip)"
FT                   /evidence="ECO:0000303|PubMed:1699275"
FT                   /id="VSP_000100"
FT   VAR_SEQ         790..793
FT                   /note="GGGD -> KDSG (in isoform Flip)"
FT                   /evidence="ECO:0000303|PubMed:1699275"
FT                   /id="VSP_000101"
FT   VARIANT         710
FT                   /note="S -> T"
FT                   /evidence="ECO:0000269|PubMed:1699275,
FT                   ECO:0000269|PubMed:8848293"
FT   MUTAGEN         645
FT                   /note="S->A: No effect on phosphorylation by CaMK2."
FT                   /evidence="ECO:0000269|PubMed:9405465"
FT   MUTAGEN         849
FT                   /note="S->A: Abolishes phosphorylation by CaMK2."
FT                   /evidence="ECO:0000269|PubMed:9405465"
FT   MUTAGEN         855
FT                   /note="R->A: Decreases binding efficiency to PRKG2."
FT   MUTAGEN         855
FT                   /note="R->E: Abolishes binding to PRKG2."
FT                   /evidence="ECO:0000269|PubMed:18031684"
FT   MUTAGEN         863
FT                   /note="S->A: Decreases synaptic insertion during chemical-
FT                   induced long term potentiation."
FT                   /evidence="ECO:0000269|PubMed:18031684"
FT   MUTAGEN         905
FT                   /note="T->A: Loss of interaction with DLG1."
FT                   /evidence="ECO:0000269|PubMed:12070168"
FT   MUTAGEN         907
FT                   /note="L->A: Loss of interaction with DLG1."
FT                   /evidence="ECO:0000269|PubMed:12070168"
FT   CONFLICT        67
FT                   /note="S -> T (in Ref. 6; AAA63479)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        248
FT                   /note="A -> R (in Ref. 6; AAA63479)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        698
FT                   /note="R -> L (in Ref. 6; AAA63479)"
FT                   /evidence="ECO:0000305"
FT   STRAND          23..32
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          34..36
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   HELIX           37..46
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          51..61
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   HELIX           67..79
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          85..87
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   HELIX           91..104
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          108..110
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          122..124
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   HELIX           130..139
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          144..149
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   TURN            151..154
FT                   /evidence="ECO:0007829|PDB:7OCA"
FT   HELIX           156..168
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          171..176
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   HELIX           177..179
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   HELIX           183..187
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   TURN            188..191
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          196..203
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   HELIX           206..208
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   HELIX           209..218
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          225..233
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   HELIX           235..237
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   HELIX           240..245
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          250..254
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          258..260
FT                   /evidence="ECO:0007829|PDB:7OCA"
FT   HELIX           261..276
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   HELIX           288..309
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   HELIX           334..342
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          346..348
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          351..353
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          359..361
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          366..372
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          375..383
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   TURN            384..386
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          387..390
FT                   /evidence="ECO:0007829|PDB:3SAJ"
FT   STRAND          409..412
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   TURN            417..419
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          420..422
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   TURN            424..428
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   HELIX           431..434
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          435..437
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   HELIX           438..450
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          454..456
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          465..467
FT                   /evidence="ECO:0007829|PDB:8C1P"
FT   TURN            469..471
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   HELIX           476..482
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          487..494
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   HELIX           497..502
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          503..505
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          509..512
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          514..518
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   HELIX           530..532
FT                   /evidence="ECO:0007829|PDB:8C2H"
FT   HELIX           537..558
FT                   /evidence="ECO:0007829|PDB:8C2H"
FT   STRAND          559..561
FT                   /evidence="ECO:0007829|PDB:7OCE"
FT   TURN            562..564
FT                   /evidence="ECO:0007829|PDB:8C2I"
FT   HELIX           587..598
FT                   /evidence="ECO:0007829|PDB:8C2H"
FT   HELIX           610..638
FT                   /evidence="ECO:0007829|PDB:8C2H"
FT   TURN            641..643
FT                   /evidence="ECO:0007829|PDB:8C1Q"
FT   HELIX           650..655
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          658..662
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          664..667
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   HELIX           668..674
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   HELIX           679..689
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          690..693
FT                   /evidence="ECO:0007829|PDB:7OCE"
FT   STRAND          697..699
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   HELIX           700..710
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          713..719
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   HELIX           720..728
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          729..731
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          735..738
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   STRAND          744..751
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   HELIX           757..769
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   HELIX           772..781
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   TURN            782..784
FT                   /evidence="ECO:0007829|PDB:8AYN"
FT   HELIX           803..832
FT                   /evidence="ECO:0007829|PDB:8C2H"
FT   STRAND          905..907
FT                   /evidence="ECO:0007829|PDB:2AWW"
SQ   SEQUENCE   907 AA;  101579 MW;  2D4CFA7CCD532838 CRC64;
     MPYIFAFFCT GFLGAVVGAN FPNNIQIGGL FPNQQSQEHA AFRFALSQLT EPPKLLPQID
     IVNISDSFEM TYRFCSQFSK GVYAIFGFYE RRTVNMLTSF CGALHVCFIT PSFPVDTSNQ
     FVLQLRPELQ EALISIIDHY KWQTFVYIYD ADRGLSVLQR VLDTAAEKNW QVTAVNILTT
     TEEGYRMLFQ DLEKKKERLV VVDCESERLN AILGQIVKLE KNGIGYHYIL ANLGFMDIDL
     NKFKESGANV TGFQLVNYTD TIPARIMQQW RTSDSRDHTR VDWKRPKYTS ALTYDGVKVM
     AEAFQSLRRQ RIDISRRGNA GDCLANPAVP WGQGIDIQRA LQQVRFEGLT GNVQFNEKGR
     RTNYTLHVIE MKHDGIRKIG YWNEDDKFVP AATDAQAGGD NSSVQNRTYI VTTILEDPYV
     MLKKNANQFE GNDRYEGYCV ELAAEIAKHV GYSYRLEIVS DGKYGARDPD TKAWNGMVGE
     LVYGRADVAV APLTITLVRE EVIDFSKPFM SLGISIMIKK PQKSKPGVFS FLDPLAYEIW
     MCIVFAYIGV SVVLFLVSRF SPYEWHSEEF EEGRDQTTSD QSNEFGIFNS LWFSLGAFMQ
     QGCDISPRSL SGRIVGGVWW FFTLIIISSY TANLAAFLTV ERMVSPIESA EDLAKQTEIA
     YGTLEAGSTK EFFRRSKIAV FEKMWTYMKS AEPSVFVRTT EEGMIRVRKS KGKYAYLLES
     TMNEYIEQRK PCDTMKVGGN LDSKGYGIAT PKGSALRNPV NLAVLKLNEQ GLLDKLKNKW
     WYDKGECGSG GGDSKDKTSA LSLSNVAGVF YILIGGLGLA MLVALIEFCY KSRSESKRMK
     GFCLIPQQSI NEAIRTSTLP RNSGAGASGG GGSGENGRVV SQDFPKSMQS IPCMSHSSGM
     PLGATGL
//
